Clinical Trial Update: Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas [Phase 1]

View source ↗

Summary

Phase 1 study of DCC-3014 in combination with Avelumab in patients with advanced or metastatic sarcoma has completed; no efficacy data is provided in the snippe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dedifferentiated Liposarcoma
• Leiomyosarcoma
• Myxofibrosarcoma
• Sarcoma
• Soft Tissue Sarcoma
• Undifferentiated Pleomorphic Sarcoma

Drugs mentioned

• Avelumab (avelumab)
• DCC-3014

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Sarcoma, Advanced Sarcoma | Phase 1 | Status: COMPLETED